APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bromhidrosis Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bromhidrosis Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173972710322 December 2025196 pages

Choose your research edition.

Industry ResearchBromhidrosis Disease Treatment Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Bromhidrosis Disease Treatment Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Bromhidrosis Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bromhidrosis Disease Treatment Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Bromhidrosis Disease Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bromhidrosis Disease Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bromhidrosis Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bromhidrosis Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bromhidrosis Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bromhidrosis Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bromhidrosis Disease Treatment include Johnson and Johnson, Novartis AG, Pfizer, AbbVie, Merz Pharma GmbH and Co. KGaA, Medytox, Journey Medical Corp, Ipsen Pharma and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bromhidrosis Disease Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bromhidrosis Disease Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bromhidrosis Disease Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bromhidrosis Disease Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Bromhidrosis Disease Treatment Segment by Company

Johnson and Johnson

Novartis AG

Pfizer

AbbVie

Merz Pharma GmbH and Co. KGaA

Medytox

Journey Medical Corp

Ipsen Pharma

Hikma Pharmaceuticals

Galderma SA

Boehringer Ingelheim International GmbH

Biovencer Healthcare

Bromhidrosis Disease Treatment Segment by Type

Antiperspirants

Botulinum Toxin

Topical Antiseptic

Bromhidrosis Disease Treatment Segment by Application

Hospital

Drugs Store

Other

Bromhidrosis Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bromhidrosis Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bromhidrosis Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bromhidrosis Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bromhidrosis Disease Treatment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bromhidrosis Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bromhidrosis Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bromhidrosis Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bromhidrosis Disease Treatment Industry Trends Table 2. Bromhidrosis Disease Treatment Industry Drivers Table 3. Bromhidrosis Disease Treatment Industry Opportunities and Challenges Table 4. Bromhidrosis Disease Treatment Industry Restraints Table 5. Global Bromhidrosis Disease Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bromhidrosis Disease Treatment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bromhidrosis Disease Treatment Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Bromhidrosis Disease Treatment Sales Market Share by Manufacturers Table 9. Global Bromhidrosis Disease Treatment Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Bromhidrosis Disease Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bromhidrosis Disease Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bromhidrosis Disease Treatment Manufacturers, Product Type & Application Table 13. Global Bromhidrosis Disease Treatment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bromhidrosis Disease Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Antiperspirants Table 17. Major Manufacturers of Botulinum Toxin Table 18. Major Manufacturers of Topical Antiseptic Table 19. Global Bromhidrosis Disease Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Bromhidrosis Disease Treatment Sales by Type (2021-2026) & (k units) Table 21. Global Bromhidrosis Disease Treatment Sales by Type (2027-2032) & (k units) Table 22. Global Bromhidrosis Disease Treatment Sales Market Share by Type (2021-2026) Table 23. Global Bromhidrosis Disease Treatment Sales Market Share by Type (2027-2032) Table 24. Global Bromhidrosis Disease Treatment Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Bromhidrosis Disease Treatment Revenue by Type (2021-2026) & (k units) Table 26. Global Bromhidrosis Disease Treatment Revenue by Type (2027-2032) & (k units) Table 27. Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2021-2026) Table 28. Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Drugs Store Table 31. Major Manufacturers of Other Table 32. Global Bromhidrosis Disease Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Bromhidrosis Disease Treatment Sales by Application (2021-2026) & (k units) Table 34. Global Bromhidrosis Disease Treatment Sales by Application (2027-2032) & (k units) Table 35. Global Bromhidrosis Disease Treatment Sales Market Share by Application (2021-2026) Table 36. Global Bromhidrosis Disease Treatment Sales Market Share by Application (2027-2032) Table 37. Global Bromhidrosis Disease Treatment Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Bromhidrosis Disease Treatment Revenue by Application (2021-2026) & (k units) Table 39. Global Bromhidrosis Disease Treatment Revenue by Application (2027-2032) & (k units) Table 40. Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2021-2026) Table 41. Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2027-2032) Table 42. Global Bromhidrosis Disease Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Bromhidrosis Disease Treatment Sales by Region (2021-2026) & (k units) Table 44. Global Bromhidrosis Disease Treatment Sales Market Share by Region (2021-2026) Table 45. Global Bromhidrosis Disease Treatment Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Bromhidrosis Disease Treatment Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Bromhidrosis Disease Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Bromhidrosis Disease Treatment Sales by Country (2021-2026) & (k units) Table 49. North America Bromhidrosis Disease Treatment Sales by Country (2027-2032) & (k units) Table 50. Europe Bromhidrosis Disease Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Bromhidrosis Disease Treatment Sales by Country (2021-2026) & (k units) Table 52. Europe Bromhidrosis Disease Treatment Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Bromhidrosis Disease Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Bromhidrosis Disease Treatment Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Bromhidrosis Disease Treatment Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Bromhidrosis Disease Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Bromhidrosis Disease Treatment Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Bromhidrosis Disease Treatment Sales by Country (2027-2032) & (k units) Table 59. Global Bromhidrosis Disease Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Bromhidrosis Disease Treatment Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Bromhidrosis Disease Treatment Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Bromhidrosis Disease Treatment Revenue Market Share by Region (2021-2026) Table 63. Global Bromhidrosis Disease Treatment Revenue Market Share by Region (2027-2032) Table 64. Johnson and Johnson Company Information Table 65. Johnson and Johnson Business Overview Table 66. Johnson and Johnson Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Johnson and Johnson Bromhidrosis Disease Treatment Product Portfolio Table 68. Johnson and Johnson Recent Development Table 69. Novartis AG Company Information Table 70. Novartis AG Business Overview Table 71. Novartis AG Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Novartis AG Bromhidrosis Disease Treatment Product Portfolio Table 73. Novartis AG Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Bromhidrosis Disease Treatment Product Portfolio Table 78. Pfizer Recent Development Table 79. AbbVie Company Information Table 80. AbbVie Business Overview Table 81. AbbVie Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. AbbVie Bromhidrosis Disease Treatment Product Portfolio Table 83. AbbVie Recent Development Table 84. Merz Pharma GmbH and Co. KGaA Company Information Table 85. Merz Pharma GmbH and Co. KGaA Business Overview Table 86. Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Product Portfolio Table 88. Merz Pharma GmbH and Co. KGaA Recent Development Table 89. Medytox Company Information Table 90. Medytox Business Overview Table 91. Medytox Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Medytox Bromhidrosis Disease Treatment Product Portfolio Table 93. Medytox Recent Development Table 94. Journey Medical Corp Company Information Table 95. Journey Medical Corp Business Overview Table 96. Journey Medical Corp Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Journey Medical Corp Bromhidrosis Disease Treatment Product Portfolio Table 98. Journey Medical Corp Recent Development Table 99. Ipsen Pharma Company Information Table 100. Ipsen Pharma Business Overview Table 101. Ipsen Pharma Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Ipsen Pharma Bromhidrosis Disease Treatment Product Portfolio Table 103. Ipsen Pharma Recent Development Table 104. Hikma Pharmaceuticals Company Information Table 105. Hikma Pharmaceuticals Business Overview Table 106. Hikma Pharmaceuticals Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Hikma Pharmaceuticals Bromhidrosis Disease Treatment Product Portfolio Table 108. Hikma Pharmaceuticals Recent Development Table 109. Galderma SA Company Information Table 110. Galderma SA Business Overview Table 111. Galderma SA Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Galderma SA Bromhidrosis Disease Treatment Product Portfolio Table 113. Galderma SA Recent Development Table 114. Boehringer Ingelheim International GmbH Company Information Table 115. Boehringer Ingelheim International GmbH Business Overview Table 116. Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Product Portfolio Table 118. Boehringer Ingelheim International GmbH Recent Development Table 119. Biovencer Healthcare Company Information Table 120. Biovencer Healthcare Business Overview Table 121. Biovencer Healthcare Bromhidrosis Disease Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Biovencer Healthcare Bromhidrosis Disease Treatment Product Portfolio Table 123. Biovencer Healthcare Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Bromhidrosis Disease Treatment Distributors List Table 127. Bromhidrosis Disease Treatment Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Bromhidrosis Disease Treatment Product Image Figure 2. Global Bromhidrosis Disease Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bromhidrosis Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Bromhidrosis Disease Treatment Sales (2021-2032) & (k units) Figure 5. Global Bromhidrosis Disease Treatment Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bromhidrosis Disease Treatment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Antiperspirants Image Figure 9. Botulinum Toxin Image Figure 10. Topical Antiseptic Image Figure 11. Global Bromhidrosis Disease Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Bromhidrosis Disease Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Bromhidrosis Disease Treatment Sales Market Share by Type (2021-2032) Figure 14. Global Bromhidrosis Disease Treatment Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Bromhidrosis Disease Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drugs Store Image Figure 19. Other Image Figure 20. Global Bromhidrosis Disease Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Bromhidrosis Disease Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Bromhidrosis Disease Treatment Sales Market Share by Application (2021-2032) Figure 23. Global Bromhidrosis Disease Treatment Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Bromhidrosis Disease Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2021-2032) Figure 26. North America Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Bromhidrosis Disease Treatment Sales Market Share by Country (2021-2032) Figure 28. U.S. Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Bromhidrosis Disease Treatment Sales Market Share by Country (2021-2032) Figure 33. Germany Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Bromhidrosis Disease Treatment Sales Market Share by Country (2021-2032) Figure 40. China Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Bromhidrosis Disease Treatment Sales Market Share by Country (2021-2032) Figure 48. Brazil Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Bromhidrosis Disease Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Bromhidrosis Disease Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Bromhidrosis Disease Treatment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Figure 59. North America Bromhidrosis Disease Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Figure 61. Europe Bromhidrosis Disease Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Bromhidrosis Disease Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Bromhidrosis Disease Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Bromhidrosis Disease Treatment Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Bromhidrosis Disease Treatment Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Antiperspirants
  • Botulinum Toxin
  • Topical Antiseptic
Applications
  • Hospital
  • Drugs Store
  • Other
Companies covered
  • Johnson and Johnson
  • Novartis AG
  • Pfizer
  • AbbVie
  • Merz Pharma GmbH and Co. KGaA
  • Medytox
  • Journey Medical Corp
  • Ipsen Pharma
  • Hikma Pharmaceuticals
  • Galderma SA
  • Boehringer Ingelheim International GmbH
  • Biovencer Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bromhidrosis Disease Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bromhidrosis Disease Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bromhidrosis Disease Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bromhidrosis Disease Treatment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bromhidrosis Disease Treatment Market Dynamics
  1. 2.1 Bromhidrosis Disease Treatment Industry Trends
  2. 2.2 Bromhidrosis Disease Treatment Industry Drivers
  3. 2.3 Bromhidrosis Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Bromhidrosis Disease Treatment Industry Restraints
3 Bromhidrosis Disease Treatment Market by Manufacturers
  1. 3.1 Global Bromhidrosis Disease Treatment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bromhidrosis Disease Treatment Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bromhidrosis Disease Treatment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bromhidrosis Disease Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bromhidrosis Disease Treatment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bromhidrosis Disease Treatment Manufacturers, Product Type & Application
  7. 3.7 Global Bromhidrosis Disease Treatment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bromhidrosis Disease Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bromhidrosis Disease Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bromhidrosis Disease Treatment Tier 1, Tier 2, and Tier 3
4 Bromhidrosis Disease Treatment Market by Type
  1. 4.1 Bromhidrosis Disease Treatment Type Introduction
  2. 4.1.1 Antiperspirants
  3. 4.1.2 Botulinum Toxin
  4. 4.1.3 Topical Antiseptic
  5. 4.2 Global Bromhidrosis Disease Treatment Sales by Type
  6. 4.2.1 Global Bromhidrosis Disease Treatment Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bromhidrosis Disease Treatment Sales by Type (2021-2032)
  8. 4.2.3 Global Bromhidrosis Disease Treatment Sales Market Share by Type (2021-2032)
  9. 4.3 Global Bromhidrosis Disease Treatment Revenue by Type
  10. 4.3.1 Global Bromhidrosis Disease Treatment Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bromhidrosis Disease Treatment Revenue by Type (2021-2032)
  12. 4.3.3 Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2021-2032)
5 Bromhidrosis Disease Treatment Market by Application
  1. 5.1 Bromhidrosis Disease Treatment Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Store
  4. 5.1.3 Other
  5. 5.2 Global Bromhidrosis Disease Treatment Sales by Application
  6. 5.2.1 Global Bromhidrosis Disease Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bromhidrosis Disease Treatment Sales by Application (2021-2032)
  8. 5.2.3 Global Bromhidrosis Disease Treatment Sales Market Share by Application (2021-2032)
  9. 5.3 Global Bromhidrosis Disease Treatment Revenue by Application
  10. 5.3.1 Global Bromhidrosis Disease Treatment Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bromhidrosis Disease Treatment Revenue by Application (2021-2032)
  12. 5.3.3 Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2021-2032)
6 Global Bromhidrosis Disease Treatment Sales by Region
  1. 6.1 Global Bromhidrosis Disease Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bromhidrosis Disease Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Bromhidrosis Disease Treatment Sales by Region (2021-2026)
  4. 6.2.2 Global Bromhidrosis Disease Treatment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bromhidrosis Disease Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bromhidrosis Disease Treatment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bromhidrosis Disease Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bromhidrosis Disease Treatment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bromhidrosis Disease Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bromhidrosis Disease Treatment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bromhidrosis Disease Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bromhidrosis Disease Treatment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bromhidrosis Disease Treatment Revenue by Region
  1. 7.1 Global Bromhidrosis Disease Treatment Revenue by Region
  2. 7.1.1 Global Bromhidrosis Disease Treatment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bromhidrosis Disease Treatment Revenue by Region (2021-2026)
  4. 7.1.3 Global Bromhidrosis Disease Treatment Revenue by Region (2027-2032)
  5. 7.1.4 Global Bromhidrosis Disease Treatment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bromhidrosis Disease Treatment Revenue (2021-2032)
  8. 7.2.2 North America Bromhidrosis Disease Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bromhidrosis Disease Treatment Revenue (2021-2032)
  11. 7.3.2 Europe Bromhidrosis Disease Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bromhidrosis Disease Treatment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bromhidrosis Disease Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bromhidrosis Disease Treatment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bromhidrosis Disease Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson and Johnson
  2. 8.1.1 Johnson and Johnson Company Information
  3. 8.1.2 Johnson and Johnson Business Overview
  4. 8.1.3 Johnson and Johnson Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson and Johnson Bromhidrosis Disease Treatment Product Portfolio
  6. 8.1.5 Johnson and Johnson Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Bromhidrosis Disease Treatment Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Bromhidrosis Disease Treatment Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 AbbVie
  20. 8.4.1 AbbVie Company Information
  21. 8.4.2 AbbVie Business Overview
  22. 8.4.3 AbbVie Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Bromhidrosis Disease Treatment Product Portfolio
  24. 8.4.5 AbbVie Recent Developments
  25. 8.5 Merz Pharma GmbH and Co. KGaA
  26. 8.5.1 Merz Pharma GmbH and Co. KGaA Company Information
  27. 8.5.2 Merz Pharma GmbH and Co. KGaA Business Overview
  28. 8.5.3 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Product Portfolio
  30. 8.5.5 Merz Pharma GmbH and Co. KGaA Recent Developments
  31. 8.6 Medytox
  32. 8.6.1 Medytox Company Information
  33. 8.6.2 Medytox Business Overview
  34. 8.6.3 Medytox Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medytox Bromhidrosis Disease Treatment Product Portfolio
  36. 8.6.5 Medytox Recent Developments
  37. 8.7 Journey Medical Corp
  38. 8.7.1 Journey Medical Corp Company Information
  39. 8.7.2 Journey Medical Corp Business Overview
  40. 8.7.3 Journey Medical Corp Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Journey Medical Corp Bromhidrosis Disease Treatment Product Portfolio
  42. 8.7.5 Journey Medical Corp Recent Developments
  43. 8.8 Ipsen Pharma
  44. 8.8.1 Ipsen Pharma Company Information
  45. 8.8.2 Ipsen Pharma Business Overview
  46. 8.8.3 Ipsen Pharma Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ipsen Pharma Bromhidrosis Disease Treatment Product Portfolio
  48. 8.8.5 Ipsen Pharma Recent Developments
  49. 8.9 Hikma Pharmaceuticals
  50. 8.9.1 Hikma Pharmaceuticals Company Information
  51. 8.9.2 Hikma Pharmaceuticals Business Overview
  52. 8.9.3 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Product Portfolio
  54. 8.9.5 Hikma Pharmaceuticals Recent Developments
  55. 8.10 Galderma SA
  56. 8.10.1 Galderma SA Company Information
  57. 8.10.2 Galderma SA Business Overview
  58. 8.10.3 Galderma SA Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Galderma SA Bromhidrosis Disease Treatment Product Portfolio
  60. 8.10.5 Galderma SA Recent Developments
  61. 8.11 Boehringer Ingelheim International GmbH
  62. 8.11.1 Boehringer Ingelheim International GmbH Company Information
  63. 8.11.2 Boehringer Ingelheim International GmbH Business Overview
  64. 8.11.3 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Product Portfolio
  66. 8.11.5 Boehringer Ingelheim International GmbH Recent Developments
  67. 8.12 Biovencer Healthcare
  68. 8.12.1 Biovencer Healthcare Company Information
  69. 8.12.2 Biovencer Healthcare Business Overview
  70. 8.12.3 Biovencer Healthcare Bromhidrosis Disease Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biovencer Healthcare Bromhidrosis Disease Treatment Product Portfolio
  72. 8.12.5 Biovencer Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bromhidrosis Disease Treatment Value Chain Analysis
  2. 9.1.1 Bromhidrosis Disease Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bromhidrosis Disease Treatment Production Mode & Process
  6. 9.2 Bromhidrosis Disease Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bromhidrosis Disease Treatment Distributors
  9. 9.2.3 Bromhidrosis Disease Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst